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Background
Due to their osteoinductive properties, recombinant
human bone morphogenetic proteins (rhBMPs) have
been used successfully for bone regeneration and repla-
cement. However, the yields rhBMPs yields in mamma-
lian expression systems are very low, resulting in their
high cost. BMPs are synthesized as a precursor,
proBMP, which undergoes enzymatic cleavage by pro-
protein convertases (PCs) to form the mature BMP [1].
Furin, an enzyme of the PC family, has shown to cleave
BMP-4 [2] and BMP-2 (Zhou et al., unpublished data).
This study investigated the effect and mechanism of
action of polyarginine furin inhibitor, IND-1, on
rhBMP-2 production in mammalian cell lines overex-
pressing rhBMP-2.
Materials and methods
Two stable cell lines expressing the hBMP2 gene, CHO-
BMP2 and HEK-BMP2, were cultured in the presence
of IND-1 in short-term (24 h, multi-well) and long-term
(two-month, perfusion flasks) cultures. The rhBMP-2
produced was characterized by Western blot and its
activity assessed using the C2C12 cell-based assay. The
amount of proBMP-2 and mature BMP-2 produced was
quantified by ELISA. The mRNA level of BMP-2 and
furin in cells treated with or without IND-1 was com-
pared by real-time RT-PCR. Cellular uptake of IND-1
was estimated by measuring the fluorescence of cell
lysates following incubation with FITC labeled IND-1.
Cellular PC activity post IND-1 incubation was mea-
sured using the Boc-RVRR-AMC substrate. Furin-speci-
fic siRNA was used to knock down the furin expression
in CHO-BMP2 cells and its effect on the rhBMP-2 pro-
duction was determined.
Results
Stably transfected CHO-BMP2 cells secreted 36 kDa
rhBMP-2 dimers that were biologically active. In 24 h
cell cultures, IND-1 treated cells produced significantly
greater amounts of proBMP-2 (≥ 10-fold, P <0.001) and
mature BMP-2 (≥ 3-fold, P <0.001) in their conditioned
medium (Figure 1). In long-term CHO-BMP2 culture,
IND-1 continued to increase the yields of BMP-2 (≥
50%) and proBMP-2 (≥ 2-fold) without affecting cell
growth or viability.
IND-1 treatment had no effect on the mRNA level of
BMP-2 and furin, indicating IND-1 affects rhBMP-2
yield post-transcriptionally. While IND-1 was taken up
by the cells and inhibited PC activity when added
directly to the cell lysates, cells cultured with IND-1
showed no changes in their PC activity at doses 50
times higher than required to affect BMP-2 yields.
Furthermore, knockdown of furin at both the mRNA (≥
80%, P <0.001) and the protein level (≥ 70%, P <0.001),
did not affect rhBMP-2 yields. These results suggest that
furin inhibition is most likely not the mechanism by
which IND-1 enhances rhBMP-2 yields.
Conclusions
The addition of a novel peptide IND-1 to the cell cul-
ture medium significantly enhanced the yields of both
pro- and mature BMP-2 in stably transfected CHO and
HEK cell lines. These increases were sustainable over an
extended time period with regular IND-1 treatments.
However, the enhanced rhBMP-2 yield is unlikely due
to the well-established role of polyarginines as furin
inhibitors.
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Figure 1 After 24 h incubation with or without IND-1, the amount of proBMP-2 and mature BMP-2 proteins in (A) CHO and (B) HEK conditioned
media were measured by proBMP-2 and BMP-2 ELISA. Data are presented as mean ± SEM (n = 3 experiments) (**P <0.01, ***P <0.001).
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